Human papillomavirus prevalence and genotypes in an opportunistically screened Irish female population

British Journal of Biomedical Science

Volumn 64, Issue 1, 2007, Pages 18-22

  Keegan, Helen ^a,b   Ryan, F ^b   Malkin, A ^b   Griffin, M ^c   Lambkin, H ^b  

^a Pathology Research Laboratory   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

Cervix dysplasia; Genotype; Human papillomavirus; Prevalence; Urban health

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DYSKARYOSIS; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 34250734929     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2007.11732750     Document Type: Article

References (33)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324: 17-27.
2. Franceschi S. The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res 2005; 166: 277-97.
3. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
4. Jenkins D, Sherlaw-Johnson C, Gallivan S. Can papilloma virus testing be used to improve cervical cancer screening? Int J Cancer 1996; 65: 768-73.
5. Syrjanen S, Shabalova I, Petrovichev N et al. Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three new independent states (NIS) of the former Soviet Union. Eur J Gynaecol Oncol 2005; 26: 491-8.
6. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006; 208: 152-64.
7. Yarkin F, Chauvin S, Konomi N et al. Detection of HPV DNA in cervical specimens collected in cytologic solution by litigation-dependent PCR. Acta Cytol 2003; 47: 450-6.
8. Cuzick J, Szarewski A, Cubie H et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003; 362: 1871-6.
9. Clavel C, Cucherousset J, Lorenzato M et al. Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer 2004; 90: 1803-8.
10. Keegan H, Malkin A, Ryan F et al. Validation of a multiplex PCR assay for the simultaneous detection of human papillomavirus and Chlamydia trachomatis in cervical PreservCyt samples. Clin Chem 2005; 51: 1301-2.
11. Ortiz M, Torres M, Munoz L et al. Oncogenic human papillomavirus (HPV) type distribution and HPV type E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 2006; 44: 1428-34.
12. Cuschieri KS, Cubie HA, Whitley MW et al. Multiple high-risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004; 57: 68-72.
13. Treanor D, Magee D, Turner L, Carroll B, Gibbons D. Incidence of cervical dyskaryosis in Ireland: report of a five-year audit. Ir Med J 2002; 95: 206-8.
14. Moscicki AB. Cervical cytology testing in teens. Curr Opin Obstet Gynecol 2005; 17: 471-5.
15. Sigurdsson K, Sigvaldason H. Longitudinal trends in cervical histological lesions (CIN 2-3+): a 25-year overview. Acta Obstet Gynecol Scand 2006; 85: 359-65.
16. Centurioni MG, Puppo A, Merlo DF et al. Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis 2005; 5: 77.
17. Matos E, Loria D, Amestoy GM et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003; 30: 593-9.
18. Beby-Defaux A, Bourgoin A, Ragot S et al. Human papillomavirus infection of the cervix uteri in women attending a health examination center of the French social security. J Med Virol 2004; 73: 262-68.
19. Bigras G, de Marval F. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women. Br J Cancer 2005; 93: 575-81.
20. Cuzick J, Beverley E, Ho L et al. HPV testing in primary screening of older women. Br J Cancer 1999; 81: 554-8.
21. Cuzick J, Sasieni P, Davies P et al. A systematic review of the role of human papillomavirus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 2000; 83: 561-5.
22. Rozendaal L, Westerga J, van der Linden JC et al. PCR-based high-risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol 2000; 53: 606-11.
23. O'Leary JJ, Landers RJ, Crowley M et al. Genotypic mapping of HPV and assessment of EBV prevalence in endocervical lesions. J Clin Pathol 1997; 50: 904-10.
24. Murphy N,Ring M, Killalea AG et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003; 56: 56-63.
25. Murphy N, Ring M, Heffron CC et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005; 58: 525-34.
26. Riethmuller D, Gay C, Bertrand X et al. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn Mol Pathol 1999; 8: 157-64.
27. Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278-85.
28. Johnson T, Bryder K, Corbet S, Fomsgaard A. Routine genotyping of human papillomavirus samples in Denmark. APMIS 2003; 111: 398-404.
29. Speich N, Schmitt C, Bollmann R, Bollmann M. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol 2004; 53: 125-8.
30. Melchers WJ, Bakkers JM, Wang J et al. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 1999; 155: 1473-8.
31. Verteramo R, Pierangeli A, Calzolari E et al. Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy. Microbes Infect 2006; 8 (9-10): 2517-21.
32. Beerens E, Van Renterghem L, Praet M et al. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes. Cytopathology 2005; 16: 199-205.
33. Clifford GM, Gallus S, Herrero R et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-8.